Managing Gas Isn't Rocket Science

... Patricia Raymond offers tips on controlling your flatulence East Longmeadow, MA (PRWEB) October 8, 2008 -- Daily flatulence is normal and necessary. In fact, the average ... gas. Determine odor - Non-smelling flatulence results from swallowed air, which is symptomatic ...

Don't Let Gas Ruin Your Summer BBQ

... School, says that we all experience flatulence and that we can get it under control with some ... AntiGas Formula to control embarrassing flatulence while with family and friends at a barbecue. ... dessert. -- Determine Odor: Non-smelling flatulence results from swallowed air, symptomatic of ...

Fighting the Gassy Effects of Good Eating, From the Harvard Health Letter

... BOSTON, Oct. 2 /PRNewswire-USNewswire/ --- flatulence isn't much fun for the person having it - or ... swallowed when people smoke. Perhaps flatulence should be added to the list of ill consequences ... this sweetener can cause bloating and flatulence in people whose small intestines can't ...

Nationwide 'GI Nurses & Associates Day' Celebrates Contributions of Gastroenterology and Endoscopy Professionals

... percent vs. 50 percent), rhinitis (42 percent vs. 36 percent), diarrhea (35 percent vs. 50 percent), abdominal pain (32 percent vs. 44 percent) and flatulence (24 percent vs. 30 percent). You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or ...

Physician Portrays Powerful Poetry at Heart of Human Condition

... A rhythmic flow of verse includes such dramatic elements as know-it-all patients, vagrants who repeatedly fall victim to street life, the miracle of flatulence and the presence of grace in the form of a small child. "Floodgates" then takes the reader down a darker road, where they experience the sorrow ...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

... events with Lialda 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (4 percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than 1 percent of patients during clinical trials and resulted ...

AMITIZA 8 mcg now available to treat irritable bowel syndrome

... most common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distention (6%), and flatulence (6%). In clinical trials of AMITIZA (8 mcg) in patients with Irritable Bowel Syndrome with Constipation, the most common adverse reactions ...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

... events with LIALDA 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (4 percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than 1 percent of patients during clinical trials and resulted ...

Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products

... It is a unique, proprietary, crystalline form of lactulose, with no restrictions on length of therapy or patient age. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, ...

MedThink Communications Selected by Salix Pharmaceuticals to Launch New Product

... of such an effect has not been studied. In clinical trials, XIFAXAN was generally well tolerated. The most common side effects (vs placebo) were flatulence 11.3% (vs 19.7%), headache 9.7% (vs 9.2%), abdominal pain 7.2% (vs 10.1%), and rectal tenesmus 7.2% (vs 8.8%). Full prescribing information may be ...

More>>

Flatulence in Medical Technology

Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week

... the most common treatment-related adverse events with Lialda 2.4 g/day, 4.8 g/day and placebo were headache (5.6%, 3.4% and 0.6%, respectively) and flatulence (4%, 2.8% and 2.8%, respectively). Pancreatitis occurred in less than 1% of patients during clinical trials and resulted in discontinuation of ...

Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed

... reported treatment-related adverse reactions (greater than or equal to 1%) in Phase 3 clinical trials were diarrhea (3.6%), abdominal pain (2.1%) and flatulence (1.1%). About GERD and EE GERD affects nearly 19 million Americans and is often characterized by frequent and persistent heartburn that occurs ...

Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW

... events with LIALDA 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (4 percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than 1 percent of patients during clinical trials and resulted ...

New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)

... most common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distention (6%), and flatulence (6%). In clinical trials of AMITIZA (8 mcg) in patients with Irritable Bowel Syndrome with Constipation, the most common adverse reactions ...

Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis

... percent vs. 50 percent), rhinitis (42 percent vs. 36 percent), diarrhea (35 percent vs. 50 percent), abdominal pain (32 percent vs. 44 percent) and flatulence (24 percent vs. 30 percent). Asacol is contraindicated in patients with hypersensitivity to salicylates. Caution should be exercised when using ...

New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG

... events with LIALDA 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (4 percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than 1 percent of patients during clinical trials and resulted ...

Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)

... reactions (greater than or equal to 4% of patients) included diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distension (6%) and flatulence (6%). For full prescribing information, visit http://www.amitiza.com . AMITIZA(R) is a registered trademark of Sucampo Pharmaceuticals, Inc. ...

Eurand Announces Positive Phase III Clinical Study Results

... weeks of treatment. Secondary endpoints included weight change, nutritional status, stool frequency and consistency, incidences of bloating, pain and flatulence as well as physician and parent or guardian judgment of clinical symptoms improvement. In the study, malabsorption symptoms were significantly ...

New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

... adverse events (greater than or equal to 5% of patients) included diarrhea (13%), headache (13%), abdominal distention (7%), abdominal pain (7%), flatulence (6%), sinusitis (5%) and vomiting (5%). For full prescribing information, visit

Abdominal bloating

... and vitaines), diarrhea , abdominal bloating , flatulence , jaundice and steatorrhea (light-coloured, ... ... , abdominal pain , abdominal bloating , and flatulence (farting). Source:MedicineNet Tuberculosis - ... a motion, cramps , abdominal bloating , flatulence , with a desire to defecate but an inability to ...

Belching

... Intestinal Gas ( Belching , Bloating , flatulence ) Intussusception Irritable Bowel Syndrome ... Colitis ) Lactose Intolerance ... flatulence is the state of having excessive stomach or ... of the back between the shoulder s. Belching , flatulence and bloating often accompany gallbladder ...

Bloating

... and breast tenderness. 1 ... BLOATING ( flatulence ; Gas) SYMPTOMS"There is an excess of gas in the ... , abdominal pain , abdominal bloating , and flatulence (farting). Source:MedicineNet Tuberculosis - ... in the lower left quadrant, bloating , and flatulence . Other symptoms, such as heartburn , lower ...

Flatulence

... flatulence (Gas) Overview Everyone has it. Most people ... the wrong time can cause great embarrassment. flatulence : Excess gas in the intestinal tract. But excess flatulence is difficult to define without a yardstick to ...

Giardia

... abdominal pain , loss of appetite , nausea , flatulence , and vomiting . Most individuals with ... smell ing diarrhea , abdominal distention, much flatulence , weight loss and a general fatigue . If ... Intestinal Gas ( Belching , Bloating , flatulence ) Intussusception Irritable Bowel Syndrome ...

Abdominal Pain

... Inflammatory Bowel Disease Intestinal Gas ( Belching , Bloating , flatulence ) ... Abdominal pain is a common symptom when there are adhesion s ... abdominal pain , especially in the lower left quadrant, bloating , and flatulence . Other symptoms, such as heartburn , lower back pain , and agitation , ...

Giardiasis

... Inflammatory Bowel Disease Intestinal Gas ( Belching , Bloating , flatulence ) Intussusception Irritable Bowel Syndrome (Spastic Colitis ) ... ) Giardiasis Gibraltar Fever ( Brucellosis ) ... Less commonly, flatulence can be a side effect of certain medications, especially cholestyramine ...

Absorption

... of mal absorption include weight loss , malnutrition (due to a lack of essential minerals and vitaines), diarrhea , abdominal bloating , flatulence , jaundice and steatorrhea (light-coloured, ... Lipid ( fat ) mal absorption is called steatorrhea. Normal lipid absorption requires ...

Bowel

... and throat. Giardiasis ( Giardia lamblia) Intestinal Complications of Inflammatory Bowel Disease Intestinal Gas ( Belching , Bloating , flatulence ) Intussusception Irritable Bowel Syndrome (Spastic Colitis ) Lactose Intolerance ... Arthritis of inflammatory bowel disease ...

Celiac

... Food Allergy Giardiasis ( Giardia lamblia) Intestinal Complications of Inflammatory Bowel Disease Intestinal Gas ( Belching , Bloating , flatulence ) Intussusception ... cushions; endocardial fibroelastosis; endocardial fibrosis; endocardial murmur ; endocardial sclerosis ; ...

More>>

Flatulence in Biological News

Stuff of stink bombs investigated for role in pregnancy

... Scientists at the University of Leicester are investigating how the stuff of stink bombs and flatulence could play a critical role in the human reproductive system. Hydrogen sulphide partially responsible for the foul odour of stink bombs- is also a ...

Flatulence in Biological Technology

Ocera Therapeutics Presents Data on AST-120 in Patients With Hepatic Encephalopathy at the European Association for the Study of Liver Disease Annual Meeting

... in pruritus, a secondary endpoint of the trial, was seen with AST-120 compared to lactulose. Adverse events related to diarrhea (p = 0.04) and flatulence (p = 0.02) were significantly less in patients treated with AST-120. The improvement seen in neurocognitive measures is consistent with reports ...

AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women

... most common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distention (6%), and flatulence (6%). In clinical trials of AMITIZA (8 mcg) in patients with Irritable Bowel Syndrome with Constipation, the most common adverse reactions ...

'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down

... most common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distention (6%), and flatulence (6%). For full prescribing information, visit http://www.amitiza.com . AMITIZA(R) is a registered trademark of Sucampo Pharmaceuticals, Inc. ...

FDA Accepts Sucampo's sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

... reactions (greater than or equal to 4% of patients) included diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distension (6%) and flatulence (6%). For full prescribing information, visit http://www.amitiza.com . AMITIZA(R) is a registered trademark of Sucampo Pharmaceuticals, Inc. ...

Flatulence in Biological Definition

Escherichia coli

... Gram-negative , rod-shaped bacteria that ferment lactose with the production of gas within 48 hours at 35C (in the body, this gas is released as flatulence ). In the fields of water purification and sewage treatment , E. coli was chosen very early in the development of the technology as an ...